ArticleScientific reports2025

Comparison of one-year outcomes between aflibercept and brolucizumab for treatment-naïve pachychoroid neovasculopathy.

Areum Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.